Please use this identifier to cite or link to this item:
http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/7511Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Paherathy, A. | |
| dc.contributor.author | Suramiya, A.A.A. | |
| dc.contributor.author | Thivacaren, S. | |
| dc.contributor.author | Shiyananth, S. | |
| dc.contributor.author | Arasalingam, A. | |
| dc.date.accessioned | 2022-09-26T05:40:46Z | - |
| dc.date.available | 2022-09-26T05:40:46Z | - |
| dc.date.issued | 2021 | |
| dc.identifier.citation | Proceedings JMA, October 2021 | en_US |
| dc.identifier.uri | http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/7511 | - |
| dc.language.iso | en | en_US |
| dc.publisher | Jaffna Medical Association | en_US |
| dc.subject | Atrial fibrillation | en_US |
| dc.subject | Novel Oral Anticoagulants (NOACS) | en_US |
| dc.title | Atrial Fibrillation– Novel Oral Anticoagulants (NOACS) as a therapeutic option. | en_US |
| dc.type | Research abstract | en_US |
| Appears in Collections: | Medicine | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
